Alan D. Feiger
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Pharmacology top 2%
- Treatment of Major Depression
Papers in
- Pharmacology 11
- Treatment of Major Depression 11
-
- Electroconvulsive Therapy Studies 4
- Attention Deficit Hyperactivity Disorder 2
- Co-authors
- Richard L. Rudolph (1 shared paper)Ari Kiev (3 shared papers)Ram Shrivastava (4 shared papers)Charles S. Wilcox (2 shared papers)Joshua D. Lipsitz (3 shared papers)Dan Zimbroff (1 shared paper)Moira A. Rynn (1 shared paper)Karl Rickels (1 shared paper)
- Journals
- The Journal of Clinical Psychiatry (3 papers)International Clinical Psychopharmacology (3 papers)European Neuropsychopharmacology (2 papers)Biological Psychiatry (1 paper)Journal of Psychiatric Research (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Alan D. Feiger
16 papers receiving 632 citations
Peers
Comparison fields: 5 of 69
- Biological Psychiatry 89
- Pharmacology 447
- Psychiatry and Mental health 350
- Experimental and Cognitive Psychology 233
- Cellular and Molecular Neuroscience 106
Countries citing papers authored by Alan D. Feiger
This map shows the geographic impact of Alan D. Feiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Feiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Feiger more than expected).
Fields of papers citing papers by Alan D. Feiger
This network shows the impact of papers produced by Alan D. Feiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Feiger. The network helps show where Alan D. Feiger may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan D. Feiger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. | 1996 | 147 |
| 2 | 1999 | 142 | |
| 3 | 1997 | 73 | |
| 4 | 2006 | 67 | |
| 5 | 1999 | 58 | |
| 6 | 2003 | 44 | |
| 7 | 2009 | 37 | |
| 8 | 1975 | 35 | |
| 9 | 2006 | 25 | |
| 10 | 2003 | 24 | |
| 11 | 2004 | 22 | |
| 12 | 2003 | 17 | |
| 13 | 1996 | 8 | |
| 14 | 2003 | 4 | |
| 15 | 1997 | 3 | |
| 16 | 2002 | 2 |
About Alan D. Feiger
Alan D. Feiger is a scholar working on Pharmacology, Psychiatry and Mental health, Experimental and Cognitive Psychology, Clinical Psychology and Statistics, Probability and Uncertainty, having authored 16 papers that have together received 708 indexed citations. Recurring topics across this work include Treatment of Major Depression (11 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers), Electroconvulsive Therapy Studies (4 papers), Child and Adolescent Psychosocial and Emotional Development (4 papers), Attention Deficit Hyperactivity Disorder (2 papers), Mental Health Research Topics (2 papers), Meta-analysis and systematic reviews (2 papers) and Neurotransmitter Receptor Influence on Behavior (2 papers). The work is most often cited by research in Biological Psychiatry (89 citations), Pharmacology (447 citations), Psychiatry and Mental health (350 citations), Experimental and Cognitive Psychology (233 citations) and Cellular and Molecular Neuroscience (106 citations). Alan D. Feiger has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Richard L. Rudolph, Ari Kiev, Ram Shrivastava, Charles S. Wilcox, Joshua D. Lipsitz, Dan Zimbroff, Moira A. Rynn, Karl Rickels, Donald S. Robinson and Jon F. Heiser. Their work appears in journals such as The Journal of Clinical Psychiatry, International Clinical Psychopharmacology, European Neuropsychopharmacology, Biological Psychiatry and Journal of Psychiatric Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.